Kinarus presents plans for a drug against Long Covid
31.05.2021
Kinarus is working on a drug against Covid-19, which is also intended to combat typical Long Covid symptoms. The medicament is aimed to be launched on the market in 2022.
News
We are hiring an additional female Board Member
11.05.2021
Der Tech Park Basel wurde über die letzten zehn Jahre im Stücki Park im Norden von Basel auf- und ausgebaut. Heute bietet er auf rund 6'700 m2 für über 30 innovative, technologieorientierte Start-ups ein inspirierendes Umfeld und verleiht der Wirtschaft im Kanton Basel- Stadt wichtige Impulse.
POLYNEURON AWARDED GRANT OF CHF 1.2M
05.05.2021
Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, today announced that the company and collaborators at the University of Basel have received a grant from the Swiss Innovation Agency Innosuisse to support a project valued at CHF 1.2 million.